HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Maria Ferreri Selected Research

Neuroblastoma

6/2005p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Maria Ferreri Research Topics

Disease

3Neoplasms (Cancer)
11/2010 - 06/2005
1Colonic Neoplasms (Colon Cancer)
11/2010
1Epilepsy (Aura)
02/2010
1Neuroblastoma
06/2005

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
11/2010 - 02/2010
2Valproic Acid (Depakote)FDA LinkGeneric
02/2010 - 06/2005
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2010
1PPAR gammaIBA
11/2010
1Retinoid X Receptors (Retinoid X Receptor)IBA
11/2010
1hydroxide ionIBA
11/2010
1Pioglitazone (Actos)FDA Link
11/2010
1ciglitazoneIBA
11/2010
1LigandsIBA
11/2010
1Histone Deacetylase InhibitorsIBA
06/2005
1Butyrates (Butyrate)IBA
06/2005
1Volatile Fatty AcidsIBA
06/2005
1Butyric Acid (Butanoic Acid)IBA
06/2005
1tributyrinIBA
06/2005

Therapy/Procedure

1Therapeutics
02/2010